ZANTE GREG
SEC insider (Form 3/4/5 filer). CIK 0001264949. Chief Financial Officer at Viking Therapeutics, Inc. (VKTX). 28 reported Form 4/5 transactions since Sep 2024; latest on Jul 29, 2026. Located in SAN DIEGO, CA.
Companies ZANTE GREG has filed insider reports for
- Viking Therapeutics, Inc. (VKTX): Officer, Chief Financial Officer
ZANTE GREG
CIK: 0001264949
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Viking Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Jul 29, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect21.2K shares at avg. $33.47$710K - Jul 28, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect31.7K shares- - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect1.5K shares at avg. $32.09$48K - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect10.3K shares at avg. $34.24$353K - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect13.9K shares at avg. $33.38$464K - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect32K shares at avg. $32.30$1.0M - Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect41K shares- - Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect32K shares- - Oct 28, 2025VKTX
Viking Therapeutics, Inc.
SaleDirect6.2K shares at avg. $35.00$216K - Oct 27, 2025VKTX
Viking Therapeutics, Inc.
AwardDirect11.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 21,217 | $33.47 | $710,141 | Direct |
| Jul 28, 2026 | VKTX Viking Therapeutics, Inc. | Award | 31,667 | - | $0 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 1,500 | $32.09 | $48,133 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 10,300 | $34.24 | $352,635 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 13,900 | $33.38 | $464,021 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 31,961 | $32.30 | $1,032,180 | Direct |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Award | 41,000 | - | $0 | Direct |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Award | 32,049 | - | $0 | Direct |
| Oct 28, 2025 | VKTX Viking Therapeutics, Inc. | Sale | 6,185 | $35.00 | $216,481 | Direct |
| Oct 27, 2025 | VKTX Viking Therapeutics, Inc. | Award | 11,117 | - | - | Direct |
1-10 of 28 transactions